For 70 years we have been taking prostate glands out of men in an attempt to “cure” prostate cancer. For about the same length of time we have been sticking needles in prostate glands in a scavenger hunt looking for cancer cells. These approaches seem logical and have become the standard of care. But there is a problem, the current approach to diagnosing and treating prostate cancer has not been demonstrated to actually cure cancer, or even help men live longer. On the other hand biopsies, surgery and radiation cause harm. How did we get stuck in this place, and is there anything we can do about it? Tune in to listen 🔊 https://vist.ly/yi42 #podcasts #Dr.StephenPetteruti #Prostatecancer #menshealth
Intellectual Medicine’s Post
More Relevant Posts
-
August 1 is #WorldLungCancerDay. The American Cancer Society predicts that there will be more than 100,000 deaths from #LungCancer this year. When lung cancer is found at an earlier stage before it spreads, it’s more likely to be treated successfully. That’s why it’s so important that more individuals get screened – even if they may not be experiencing symptoms. At On Target, we’re committed to helping patients and doctors fight this disease. Our targeted intraoperative molecular imaging agent helps surgeons visualize early-stage lung cancer, remove more cancer during surgery, and contributes to a world with better #LungHealth. #WLCD24 To learn more about our intraoperative molecular imaging agent and risk related information, please visit https://bit.ly/3yr0tVN
To view or add a comment, sign in
-
High-dose vitamin D significantly reduced bone loss in patients with prostate cancer - Luke Peppone https://lnkd.in/gUTeamUV #oncodaily #oncology #cancer #research #prostatecancer #ClinicalTrials
To view or add a comment, sign in
-
🎗 Most people know that October is Breast Cancer Awareness Month – but did you know that around 2 in 3 breast cancer patients receive radiotherapy as part of their treatment? Radiotherapy is often recommended when a tumor cannot be fully removed with surgery, or after surgery to reduce the risk of recurrence. It’s also crucial for treating breast cancer that has spread to other areas of the body and for relieving symptoms in advanced cases. However, many patients and members of the public still hold misconceptions about radiotherapy due to outdated information and misleading sources, which can cause unnecessary fear and, unfortunately, prevent people from accessing life-saving treatments. To help address these misconceptions, our radiotherapy experts from across Ergéa Group have debunked some of the most common myths surrounding radiotherapy in breast cancer. Take a look through the carousel below to learn more, and feel free to share to help others make informed treatment decisions! #BreastCancerAwareness #BreastCancerTreatment #Radiotherapy #CancerCare #Oncology #ErgéaGroup Sejal Patel Ilaria Bonaparte Sandra Röddiger Simona Castiglioni Dr. med. Caterina Wimmer RadioOnkologieNetzwerk - Ergéa Group Medipass - Ergéa Group
To view or add a comment, sign in
-
DID YOU KNOW? Circulating tumor DNA or ctDNA is not cancer cells in your blood. ctDNA is actually fragmented DNA from your tumor found in the blood. ctDNA testing is also called liquid biopsy. ctDNA has multiple usages and research is ongoing to find ways to utilize it in current cancer treatment. Some ways it can be used are: 1. ctDNA can be used to test for changes in biomarker status which can lead to a change in treatment. 2. ctDNA can be measured in blood to identify the presence of residual cancer cells after surgery or to monitor for cancer recurrence after successful treatment. 3. Changes in ctDNA level over time can give information about how well a treatment is working. #bustingcancermyths #cancersucks #ctDNA
To view or add a comment, sign in
-
In the latest episode of my podcast, “The Immuno-Oncology Curve,” I'm joined by my Agenus colleagues Dr. Joseph Grossman and Dr. Benny Johnson. We talk about why we left the practice of medicine for Agenus. And, we reflect on this year’s #ASCO GI Cancers Symposium, covering the rise of early-onset cancers, the promising use of circulating tumor DNA (ctDNA) as a biomarker, the ongoing challenge of diversity in cancer clinical trials, and the overall potential of I-O to reduce dependence on chemotherapy and surgery. Listen and subscribe at: https://bit.ly/4bNIAzJ
To view or add a comment, sign in
-
DID YOU KNOW? Circulating tumor DNA or ctDNA is not cancer cells in your blood. ctDNA is actually fragmented DNA from your tumor found in the blood. ctDNA testing is also called liquid biopsy. ctDNA has multiple usages and research is ongoing to find ways to utilize it in current cancer treatment. Some ways it can be used are: 1. ctDNA can be used to test for changes in biomarker status which can lead to a change in treatment. 2. ctDNA can be measured in blood to identify the presence of residual cancer cells after surgery or to monitor for cancer recurrence after successful treatment. 3. Changes in ctDNA level over time can give information about how well a treatment is working. #bustingcancermyths #ctDNA #cancersucks
To view or add a comment, sign in
-
Metastatic cancer is responsible for the majority of cancer-related deaths since surgery and subsequent radio- or chemotherapy often fail to remove all cancer cells. In addition, metastases frequently develop immunosuppressive resistance mechanisms protecting them from immunotherapy that work well in primary tumors. Researchers at Technische Universität München developed cells to be used in NK-or T-cell based therapies that overcome the immunosuppressive tumor microenvironment and thus retain their full cytotoxic activity. To read more click here: https://lnkd.in/ddSNnbT9
To view or add a comment, sign in
-
𝐃𝐚𝐲 𝟓 𝐨𝐟 𝐁𝐫𝐞𝐚𝐬𝐭 𝐜𝐚𝐧𝐜𝐞𝐫! Today, we’re diving into the crucial treatment options available for breast cancer. From surgery to radiation therapy and the innovative use of the perfusor during chemotherapy, each treatment is a tailored approach that empowers patients in their fight against cancer. Understanding these options is vital for making informed decisions alongside your healthcare team. This knowledge can be a powerful ally on the journey to recovery. We hope this series has equipped you with valuable insights and encourages ongoing conversations about breast cancer awareness. #zuvius #cancer #cancerawareness #fightcancer #beatcancer Nimishh Thakkar; Shailesh Shetty; Alka Chavan; Swapnil Kamble
To view or add a comment, sign in
-
Laparoscopic cholecystectomy frequently reveals gallbladder cancers (GBCs), often previously undiagnosed. Given the poor prognosis of GBC, understanding factors influencing outcomes is vital. A systematic review by Dr. Kavin Sugumar explores the prognostic significance of biliary spillage (BS)—the accidental leakage of bile during surgery—finding that BS might worsen survival rates by spreading cancer cells. These insights could reshape surgical practices and improve postoperative management for GBC patients. #TulaneResearch #Cancer #Oncology Read the paper in the comments! Image: Results from individual studies and aggregated data suggest bile spillage is associated with decreased overall survival.
To view or add a comment, sign in
-
Mr Sheng Qiu is a Consultant Colorectal and General Surgeon with a special interest in advanced and complex colorectal cancer. Mr Qiu has experience in pelvic exenteration surgery for locally advanced and recurrent rectal cancers. He also works with liver surgeons performing simultaneous bowel and liver resections, treating patients with metastatic colorectal cancer. Mr Qiu's research interests include novel biomarkers in cancer, personalisation of cancer treatment, and the consequences of colorectal cancer treatment. Read his full profile: https://bit.ly/3U3Lo58 #LikeNoOther #BowelCancerAwarenessMonth
To view or add a comment, sign in
104 followers